Glasgow life sciences pioneer behind IBS treatment gets £19m boost in one of largest investments of its kind
“Our mission is to redefine the standard of care in gastrointestinal disease” – James McIlroy, founder and CEO
Original Source
Read the full article at Scotsman →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.